4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-003737
Senior VP - Drug Discovery gave up 9,387 shares (to pay taxes)
- Senior VP - Drug Discovery acquired 31,874 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Babu Yarlagadda S · Senior VP - Drug Discovery
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-01-31 | Exercise or conversion : show line 1 in the form | +19,686 | $1.20 | $23,623 | 127,786 | D |
| 2019-01-31 | Shares withheld for taxes : show line 2 in the form | −7,702 | $8.68 | $66,853 | 120,084 | D |
| 2019-01-31 | Exercise or conversion : show line 3 in the form | +12,188 | $1.20 | $14,626 | 132,272 | D |
| 2019-01-31 | Shares withheld for taxes : show line 4 in the form | −1,685 | $8.68 | $14,626 | 130,587 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-31 | Exercise or conversion : show line 5 in the form Non-Qualified Stock Option | −19,686 | 0 | D |
| 2019-01-31 | Exercise or conversion : show line 6 in the form Emp. Stock Option (Right to Buy) | −12,188 | 0 | D |
Loading xslF345X03/form4.xml…